^
4ms
New P1/2 trial • Combination therapy • Metastases
|
Avastin (bevacizumab) • Tyvyt (sintilimab) • Kaitanni (cadonilimab) • Yidafan (ivonescimab) • lancastotug (AK127)
8ms
Phase classification • Combination therapy • Metastases
|
Kaitanni (cadonilimab) • lancastotug (AK127)
over1year
New P1/2 trial
|
Yidafan (ivonescimab) • lancastotug (AK127)
over1year
New P1 trial • Combination therapy • Metastases
|
Kaitanni (cadonilimab) • lancastotug (AK127)